LA JOLLA, CALIF. – Sept 01, 2022 – Researchers at Sanford Burnham Prebys, led by Ze’ev Ronai, Ph.D., have shown for the first time that inhibiting...
Durham-based BioCryst, which discovers and develops medicines to treat rare diseases, said the U.S. Food and Drug Administration has granted orphan drug...
Company set to introduce psychedelic product catalogue showcasing in-house EU-GMP manufacturing expertise Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF)...
MorphoSys made it clear when it shuttered all US-based discovery work earlier this year that it wants to keep its focus in its home base of...
Sanofi now has approval on both sides of the Atlantic for Xenpozyme – its enzyme replacement therapy for The post Xenpozyme is first FDA-approved drug...
Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available The post Dr. B: Expanding the business...